A muscular man who trains five days a week walks into a doctor’s office. His BMI says he is overweight, bordering on obese. A sedentary man with a soft midsection and high visceral fat walks into the same office. His BMI says he is in the normal range. Both readings are wrong in the way that matters, and both come from a formula that was never designed to evaluate an individual person.
BMI has been the default measure of body weight status in medicine for decades. It is free, it takes two seconds to calculate, and it works acceptably for tracking trends across large populations. As a tool for judging whether a specific 50-year-old professional is metabolically healthy, it fails often enough to be misleading.
This post explains where BMI came from, the two ways it fails, and the metrics that actually predict metabolic risk. None of them require expensive equipment, and the best ones you can track yourself.
Where BMI Actually Came From
BMI is not a medical invention. It was created in the 1830s by Adolphe Quetelet, a Belgian mathematician and astronomer who was studying the characteristics of the average person across populations. He was not a physician, and he was not trying to diagnose anyone. He was doing population statistics.
The formula (weight divided by height squared) was designed to describe the distribution of body weight across a group of people. Quetelet himself noted that it was not meant to measure the body fat of any individual. It was a tool for describing populations, and for that purpose it works reasonably well.
The medical adoption of BMI as an individual screening tool came much later, in the 20th century, largely because it was cheap and easy. Insurance companies and researchers needed a simple number, and BMI provided one. The convenience drove the adoption, not the accuracy. A formula built for 19th-century population statistics became the default tool for evaluating individual patients in the 21st century, and the mismatch has consequences.
The Two Ways BMI Fails
BMI produces two opposite errors, and both are common in the affluent professional demographic.
The first error is misclassifying muscular people as overweight or obese. BMI cannot tell muscle from fat. It only knows total weight relative to height. A man who has built significant muscle through years of training carries more weight than a sedentary man of the same height, and BMI reads that extra weight as excess. Athletes and people who lift weights routinely get flagged as overweight by BMI despite having low body fat and excellent metabolic health. The number is measuring their muscle and calling it a problem.
The second error is more dangerous because it misses real risk. There is a phenotype that researchers call metabolically obese normal weight, sometimes shortened to “skinny fat.” These are people whose BMI falls in the normal range but who carry excess visceral fat, have insulin resistance, and show the metabolic dysfunction that drives cardiovascular disease and diabetes. BMI gives them a clean bill of health while their actual metabolic picture is deteriorating. A person can have a perfectly normal BMI and a fasting insulin level that signals serious trouble, which we covered in the post on HbA1c and the insulin connection.
The professional in their 40s and 50s is a prime candidate for the second error. Years of sedentary work, gradual muscle loss, and visceral fat accumulation can produce metabolic dysfunction in someone whose weight never crossed a BMI threshold. The number says they are fine. Their body says otherwise.
Why Visceral Fat Is the Metric That Matters
Not all body fat carries the same risk. Subcutaneous fat (the fat directly under the skin, on the arms, legs, and hips) is relatively benign metabolically. Visceral fat (the fat stored deep in the abdomen, surrounding the organs) is the dangerous kind.
Visceral fat is metabolically active in harmful ways. It releases inflammatory signaling molecules, drives insulin resistance, and is strongly associated with cardiovascular disease, type 2 diabetes, and other metabolic conditions. Two people with identical BMIs can have very different amounts of visceral fat, and therefore very different health risks. The one with more visceral fat is in a worse position regardless of what the scale or the BMI says.
This is why measuring fat distribution matters more than measuring total weight. Where you store fat tells you more about your metabolic risk than how much you weigh.
Better Metrics, In Order of Usefulness
Several metrics do a better job than BMI of capturing what actually matters. Here they are, roughly in order of accessibility and clinical value.
Waist-to-height ratio is free, takes seconds, and predicts cardiovascular risk surprisingly well. You measure your waist circumference at the level of your navel and divide it by your height in the same units. A common guideline is to keep your waist circumference under half your height. So a person who is 70 inches tall should aim for a waist under 35 inches. This single ratio outperforms BMI as a predictor of metabolic risk in much of the research, and you can measure it at home with a tape measure.
Waist circumference alone is also useful, with the caveat that the meaningful cutoffs vary by sex and ethnicity. Elevated waist circumference is a marker of visceral fat accumulation. It is part of the standard criteria for metabolic syndrome for this reason.
Body fat percentage gives you the muscle-versus-fat picture that BMI misses entirely. It can be estimated through skinfold calipers or bioelectrical impedance scales, though both methods have meaningful error margins and can vary based on hydration and other factors. They are better than BMI at distinguishing body composition, but treat the exact number as an estimate rather than a precise reading.
DEXA scanning is the accessible gold standard. A DEXA scan measures fat mass, lean mass, and bone density, and many machines can estimate visceral adipose tissue specifically. It gives you a detailed body composition breakdown that no formula can match. DEXA scans are increasingly available at clinics and imaging centers, and a single scan provides a baseline you can track against over time. For someone serious about understanding their body composition, a DEXA scan is worth the modest cost.
MRI is the research-grade method for measuring visceral fat with the most precision, but it is expensive and not necessary for routine assessment. For nearly everyone, DEXA provides more than enough detail.
Why GLP-1 Decisions Should Not Rely on BMI Alone
Insurance criteria for GLP-1 medications and many clinical protocols use BMI cutoffs to determine eligibility. This creates a problem. A patient with significant visceral fat and metabolic dysfunction who falls just below the BMI cutoff may benefit substantially from treatment, while a muscular patient above the cutoff may not need it at all. The BMI threshold does not match the actual clinical need in either case.
A better approach evaluates body composition and metabolic markers alongside any weight measurement. The decision to use a GLP-1 should rest on the full picture: visceral fat, insulin sensitivity, lipid markers, and overall metabolic health, not a single number that cannot distinguish muscle from fat. The same logic applies to tracking progress on these medications. Watching body composition change tells you far more than watching the scale, especially given the muscle preservation concerns we covered in the post on GLP-1 muscle loss.
What Healthy Body Composition Looks Like After 40
For a high-functioning professional in their 40s or 50s, the target is not a BMI number. It is a body composition that supports strength, metabolic health, and longevity.
That generally means a healthy amount of muscle mass (enough to support metabolic rate, insulin sensitivity, and functional strength as you age), low visceral fat (the inflammatory, metabolically harmful kind), and a body fat percentage in a range that varies by individual but is well below the levels associated with metabolic dysfunction. The exact numbers differ by person, sex, and starting point. The principle is consistent: build and keep muscle, minimize visceral fat, and stop using a single weight number as the measure of success.
How We Build Weight Management Plans
At Towsen Clinic, weight management plans are built around body composition and metabolic markers rather than BMI alone. The evaluation looks at where you store fat, how your metabolic markers read, and what your muscle status is, because those are the things that actually predict your health trajectory. The scale is one data point among several, and not the most important one. The full approach is on the weight management therapy page, and because body composition and hormone status are deeply linked, the evaluation often overlaps with the hormone optimization program.
If you have been told you are overweight by a number that does not match how you look and feel, or if you suspect a normal BMI is hiding a metabolic problem, schedule a consultation and we will measure what actually matters.
